Back
[Squamous cell carcinoma of the hypopharynx and larynx: evidence-based care].
Journal article

[Squamous cell carcinoma of the hypopharynx and larynx: evidence-based care].

  • Fayette J Université de Lyon, Centre Léon-Bérard, Service de médecine, 28, rue Laennec, 69008 Lyon, France.
  • Pointreau Y Centre Jean-Bernard, Clinique Victor-Hugo, Service de radiothérapie, 9, rue Beauverger 72000 Le Mans, France.
  • Bourhis J Centre hospitalier universitaire Vaudois, Service de radiothérapie, 46, rue du Bugnon, 1011 Lausanne, Suisse.
  • Lefebvre JL Centre Oscar-Lambret, Service de chirurgie maxillofaciale, 3, rue Frédéric-Combemale, 59000 Lille, France.
Show more…
  • 2014-06-03
Published in:
  • Bulletin du cancer. - 2014
TPF
chemoradiotherapy
hypopharynx
induction
larynx
Antineoplastic Agents
Carcinoma, Squamous Cell
Chemoradiotherapy
Evidence-Based Medicine
Humans
Hypopharyngeal Neoplasms
Laryngeal Neoplasms
Lymphatic Metastasis
Neoplasm Staging
Tumor Burden
English Squamous cell carcinomas of larynx and hypopharynx can be treated by surgery and/or radiotherapy according to tumor size. For small tumors, the results are similar. For locally advanced tumors, the surgical approach is mutilating and requires a total (pharyngo)laryngectomy. Exclusive chemoradiotherapy has shown its interest at the cost of late sequelae. In order to reduce these effects and mutilation, induction chemotherapy with cisplatin, docetaxel and 5FU for organ preservation becomes the standard treatment but there are no solid studies comparing this approach with the exclusive chemoradiotherapy. And it is not possible to conclude as to the superiority of a scheme in terms of overall survival. When chemotherapy is chosen, the modalities of any potentiation of radiation have not been yet established.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/181416
Statistics
Document views: 18 File downloads: